Deseret Mutual Benefit Administrators’s Vertex Pharmaceuticals VRTX Stock Holding History

Deseret Mutual Benefit Administrators's VRTX Position: Q1 2026 in Review

Deseret Mutual Benefit Administrators reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, selling an estimated $25.2K and leaving 342 shares worth $153K. The position accounts for 0.05% of the portfolio, ranked #239.

Deseret Mutual Benefit Administrators first reported a position in VRTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $180K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

• Deseret Mutual Benefit Administrators held 342 shares of Vertex Pharmaceuticals worth $153K as of Q1 2026.
• Deseret Mutual Benefit Administrators sold 54 Vertex Pharmaceuticals shares in Q1 2026, an estimated $25.2K.
• Vertex Pharmaceuticals made up 0.05% of Deseret Mutual Benefit Administrators's portfolio in Q1 2026, its #239 holding.
• Deseret Mutual Benefit Administrators first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
• Deseret Mutual Benefit Administrators's Vertex Pharmaceuticals position peaked at $180K in Q4 2025.
• 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q1 2026, filed 8 May 2026.